Allotment of 5 lakh shares on warrant conversion to promoter entity

Warrants ConvertedFund Raising View source PDF Explain this filing

MEDICAMEQ · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-5.3%Reaction day

₹266.00

prior close

₹251.90

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-2.3%-3.0% vs market

Pharmaceuticals peers, median of 170sector-1.5%-3.8% vs sector

On the reaction day the stock moved 3.0 pts less than Nifty Microcap 250 and 3.8 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+2.3

10m

+2.3

15m

+2.2

30m

+2.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-5.3-2.3-3.0-1.5-3.8

Next day

-1.1-1.9+0.8-0.4-0.7

-0.8-0.2-0.6+1.5-2.4

-4.1-0.2-4.0+2.5-6.6

+0.4+0.5-0.1+2.7-2.4

-3.8pendingpending+1.6-5.4

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 170Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

On October 23, 2026, the committee approved conversion of 5,00,000 fully convertible warrants into equity shares at Rs 530 each. The shares were allotted to Shivalik Rasayan Limited, a promoter-group entity, for Rs 26.50 crore. Post-allotment, paid-up capital is Rs 14.06 crore, comprising 1,40,62,815 shares of Rs 10 each.

Likely market impact

The share count and paid-up capital rise, causing modest dilution. The converted warrants will no longer create further share dilution.